Association of Thyroid Hormone Levels with Microvascular Complications in Euthyroid Type 2 Diabetes Mellitus Patients

References

• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl 2):S14–21.
   PubMed Web of Science ®Google Scholar
• Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.
   PubMed Web of Science ®Google Scholar
• Cheema S, Maisonneuve P, Zirie M, et al. Risk factors for microvascular complications of diabetes in a high-risk middle east population. J Diabetes Res. 2018;2018:8964027.
   PubMed Web of Science ®Google Scholar
• Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications. 2012;26(2):123–128.
   Web of Science ®Google Scholar
• Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–2474.
   PubMed Web of Science ®Google Scholar
• Yamazaki D, Hitomi H, Nishiyama A. Hypertension with diabetes mellitus complications. Hypertens Res. 2018;41(3):147–156.
   Web of Science ®Google Scholar
• Zhao W, Zeng H, Zhang X, et al. A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2016;115:122–129.
   Web of Science ®Google Scholar
• Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39–55.
   PubMed Web of Science ®Google Scholar
• Johnson L, Rayner B. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism. Cardiovasc J Afr. 2020;31(1):5–8. doi:10.5830/CVJA-2019-036
   Web of Science ®Google Scholar
• Mansournia N, Riyahi S, Tofangchiha S, et al. Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes. J Endocrinol Invest. 2017;40(3):289–295.
   Web of Science ®Google Scholar
• Mehalingam V, Sahoo J, Bobby Z, Vinod KV. Thyroid dysfunction in patients with type 2 diabetes mellitus and its association with diabetic complications. J Family Med Primary Care. 2020;9(8):4277–4281.
   Google Scholar
• Wu J, Li X, Tao Y, Wang Y, Peng Y. Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes. Int J Endocrinol. 2015;2015:204893.
   Web of Science ®Google Scholar
• Wang J, Li H, Tan M, et al. Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China. Oncotarget. 2019;10(2):88–97.
   Google Scholar
• Zou J, Li Z, Tian F, et al. Association between normal thyroid hormones and diabetic retinopathy in patients with type 2 diabetes. Biomed Res Int. 2020;2020:8161797.
   Web of Science ®Google Scholar
• Kong X, Wang J, Gao G, et al. Association between free thyroxine levels and diabetic retinopathy in euthyroid patients with type 2 diabetes mellitus. Endocr Res. 2020;45(2):111–118.
   PubMed Web of Science ®Google Scholar
• Hu Y, Yan Z, Pan C. Associations of thyroid hormone levels and macrovascular complications in euthyroid type 2 diabetic patients. Diabetes Metab Syndr Obes. 2021;14:2683–2691.
   Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
   PubMed Web of Science ®Google Scholar
• Martin CL, Albers JW, Pop-Busui R. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):31–38.
   PubMed Web of Science ®Google Scholar
• Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S84–87.
   PubMed Web of Science ®Google Scholar
• Penza P, Lombardi R, Camozzi F, Ciano C, Lauria G. Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy. Neurol Sci. 2009;30(2):149–151.
   Web of Science ®Google Scholar
• Yerdelen D, Ertorer E, Koç F. The effects of hypothyroidism on strength-duration properties of peripheral nerve. J Neurol Sci. 2010;294(1–2):89–91.
   PubMed Web of Science ®Google Scholar
• Han C, He X, Xia X, et al. Subclinical Hypothyroidism and Type 2 Diabetes: a Systematic Review and Meta-Analysis. PLoS One. 2015;10(8):e0135233.
   PubMed Web of Science ®Google Scholar
• Zhu FF, Yang LZ. The association between the levels of thyroid hormones and peripheral nerve conduction in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2018;126(8):493–504.
   PubMed Web of Science ®Google Scholar
• Han Q, Zhang J, Wang Y, et al. Thyroid hormones and diabetic nephropathy: an essential relationship to recognize. Nephrology. 2019;24(2):160–169.
   PubMed Web of Science ®Google Scholar
• Liu P, Liu R, Chen X, et al. Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study. Curr Med Res Opin. 2015;31(12):2233–2240.
   PubMed Web of Science ®Google Scholar
• Zou J, Tian F, Zhang Y, et al. Association between Thyroid Hormone Levels and Diabetic Kidney Disease in Euthyroid Patients with Type 2 Diabetes. Sci Rep. 2018;8(1):4728.
   Web of Science ®Google Scholar
• Zhao W, Li X, Liu X, Lu L, Gao Z. Thyroid Function in patients with type 2 diabetes mellitus and diabetic nephropathy: a single center study. J Thyroid Res. 2018;2018:9507028.
   Web of Science ®Google Scholar
• Lin Y, Sun Z. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. J Endocrinol. 2011;209(2):185–191.
   Web of Science ®Google Scholar
• Yang JK, Liu W, Shi J, Li YB. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care. 2010;33(5):1018–1020.
   PubMed Web of Science ®Google Scholar
• Wu J, Yue S, Geng J, et al. Relationship between diabetic retinopathy and subclinical hypothyroidism: a meta-analysis. Sci Rep. 2015;5:12212.
   PubMed Web of Science ®Google Scholar
• López-Noriega L, Cobo-Vuilleumier N, Narbona-Pérez ÁJ, et al. Levothyroxine enhances glucose clearance and blunts the onset of experimental type 1 diabetes mellitus in mice. Br J Pharmacol. 2017;174(21):3795–3810.
   Web of Science ®Google Scholar
• Lin Y, Sun Z. Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. Br J Pharmacol. 2011;162(3):597–610.
   PubMed Web of Science ®Google Scholar
• Kim BY, Kim CH, Jung CH, Mok JO, Suh KI, Kang SK. Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes. Endocr J. 2011;58(12):1065–1070.
   Web of Science ®Google Scholar
• Stefanowicz-Rutkowska MM, Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz EM. Thyroid dysfunction in patients with diabetic retinopathy. Endokrynol Pol. 2020;71(2):176–183.
   Web of Science ®Google Scholar
• Lu M, Yang CB, Gao L, Zhao JJ. Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review). Exp Ther Med. 2015;9(1):3–10.
   PubMed Web of Science ®Google Scholar
• Nukada H. Ischemia and diabetic neuropathy. Handb Clin Neurol. 2014;126:469–487.
   PubMedGoogle Scholar
• Vicinanza R, Coppotelli G, Malacrino C, et al. Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid. 2013;23(2):231–238.
   Web of Science ®Google Scholar
• Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2003;88(8):3731–3737.
   PubMed Web of Science ®Google Scholar
• Mantzouratou P, Lavecchia AM, Novelli R, Xinaris C. Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a “Switch” to the Foetal Gene Programme. Curr Diab Rep. 2020;20(11):58.
   Web of Science ®Google Scholar
• Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438–2444.
   PubMed Web of Science ®Google Scholar
• Oflaz H, Kurt R, Cimen A, et al. Coronary flow reserve is also impaired in patients with subclinical hypothyroidism. Int J Cardiol. 2007;120(3):414–416.
   Web of Science ®Google Scholar
• Glaschke A, Weiland J, Del Turco D, Steiner M, Peichl L, Glösmann M. Thyroid hormone controls cone opsin expression in the retina of adult rodents. J Neurosci. 2011;31(13):4844–4851.
   Web of Science ®Google Scholar
• Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: two Closely Associated Disorders. Endocr Rev. 2019;40(3):789–824.
   PubMed Web of Science ®Google Scholar